Clinical trial
Vaccine Therapy in Treating Patients With Liver Cancer
NCT00005629 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005629 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Liver Cancer |
| Official title | Phase I/II Trial Testing Alpha Fetoprotein (AFP) Peptide Immunization in Hepatocellular Carcinoma |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Biological |
| Interventions | AFP gene hepatocellular carcinoma vaccine |
| Enrollment | 6 |
| Start date | Jul 1, 1999 |
| Primary completion | May 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Oct 1, 2003 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: